Menu
GWAS Study

Multi-ancestry genome-wide association study identifies 27 loci associated with measures of hemolysis following blood storage.

Page GP, Kanias T, Guo YJ et al.

34014839 PubMed ID
GWAS Study Type
12219 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

PG
Page GP
KT
Kanias T
GY
Guo YJ
LM
Lanteri MC
ZX
Zhang X
MA
Mast AE
CR
Cable RG
SB
Spencer BR
KJ
Kiss JE
FF
Fang F
ES
Endres-Dighe SM
BD
Brambilla D
NM
Nouraie M
GV
Gordeuk VR
KS
Kleinman S
BM
Busch MP
GM
Gladwin MT
Chapter II

Abstract

Summary of the research findings

BackgroundThe evolutionary pressure of endemic malaria and other erythrocytic pathogens has shaped variation in genes encoding erythrocyte structural and functional proteins, influencing responses to hemolytic stress during transfusion and disease.MethodsWe sought to identify such genetic variants in blood donors by conducting a genome-wide association study (GWAS) of 12,353 volunteer donors, including 1,406 African Americans, 1,306 Asians, and 945 Hispanics, whose stored erythrocytes were characterized by quantitative assays of in vitro osmotic, oxidative, and cold-storage hemolysis.ResultsGWAS revealed 27 significant loci (P < 5 × 10-8), many in candidate genes known to modulate erythrocyte structure, metabolism, and ion channels, including SPTA1, ALDH2, ANK1, HK1, MAPKAPK5, AQP1, PIEZO1, and SLC4A1/band 3. GWAS of oxidative hemolysis identified variants in genes encoding antioxidant enzymes, including GLRX, GPX4, G6PD, and SEC14L4 (Golgi-transport protein). Genome-wide significant loci were also tested for association with the severity of steady-state (baseline) in vivo hemolytic anemia in patients with sickle cell disease, with confirmation of identified SNPs in HBA2, G6PD, PIEZO1, AQP1, and SEC14L4.ConclusionsMany of the identified variants, such as those in G6PD, have previously been shown to impair erythrocyte recovery after transfusion, associate with anemia, or cause rare Mendelian human hemolytic diseases. Candidate SNPs in these genes, especially in polygenic combinations, may affect RBC recovery after transfusion and modulate disease severity in hemolytic diseases, such as sickle cell disease and malaria.

Up to 7,586 non-Hispanic White ancestry individuals, Up to 1,049 East Asian ancestry individuals, Up to 257 South Asian ancestry individuals, Up to 1,046 African Americans individuals, Up to 456 Mexican and Central American Hispanics individuals, Up to 489 Caribbean Island Hispanics, Up to 1,336 individuals

Chapter III

Study Statistics

Key metrics and study information

12219
Total Participants
GWAS
Study Type
No
Replicated
Native American, NR, Oceanian, European, East Asian, South Asian, Hispanic or Latin American, African American or Afro-Caribbean
Ancestry
U.S.
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.